
Renal disease is a major cause of mortality and morbidity in systemic lupus zzso Among the zzso classes of lupus zzso zzso zzso comprises only one-fifth of all zzso zzso survival and rates of zzso zzso disease in zzso lupus zzso zzso vary zzso because of substantial zzso among the published zzso The risk of progression from zzso to zzso failure is generally reduced in the absence of zzso zzso but patients are, zzso at risk of zzso zzso The optimal therapy for zzso remains elusive because of a lack of controlled zzso however, cardiovascular protection and blockade of the zzso system should be instituted early in all zzso Mixed zzso and zzso lupus zzso should be treated in the same way as pure zzso lupus zzso If zzso is not accompanied by zzso zzso but is associated with clinically relevant zzso zzso zzso or failure to respond to supportive therapies, zzso treatment is zzso Treatment options include zzso combined with zzso zzso zzso or zzso zzso The efficacy of zzso zzso in zzso remains to be zzso Controlled trials to compare existing zzso agents and experimental zzso such as zzso zzso and zzso should be undertaken in the zzso 

